Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Rocuronium-induced Neuromuscular Blockade by Sugammadex in Children Younger Than 2 Years Old: a Prospective Dose Finding Study

NCT06575036 is registered in ClinicalTrials.gov with Sang-Hwan Ji as lead sponsor.

NCT NCT06575036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06575036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Rocuronium-induced Neuromuscular Blockade by Sugammadex in Children Younger Than 2 Years Old: a Prospective Dose Finding Study
Lead sponsor
Sang-Hwan Ji
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 15, 2024
Completion date
May 31, 2025
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade